Oral, but not transdermal, administration of estrogens lowers tissue-type plasminogen activator levels in humans without affecting its endothelial synthesis

E.J. Giltay, L.J.G. Gooren, J.J. Emeis, T. Kooistra, C.D.A. Stehouwer

Research output: Contribution to journalArticleAcademicpeer-review

4 Downloads (Pure)
Original languageEnglish
Pages (from-to)1396-1403
JournalArteriosclerosis, Thrombosis, and Vascular Biology
Volume36(3)
DOIs
Publication statusPublished - 2000

Cite this